PFI - Profiting From Infirmaries
* Για όσους δεν γνωρίζουν ποιός είναι ο Martin McKee, περισσσότερα εδώ... http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)60748-5/fulltext https://en.wikipedia.org/wiki/Martin_McKee
This report looks at the significant profits made by PFI companies from NHS contracts over the last 6 years.
Analysis of accounting data from the Treasury and Companies House for the period 2010 to 2015 finds: Over the past 6 years, companies which run PFI contracts to build and run NHS hospitals and other facilities have made pre-tax profits of £831m – money which has thereby not been available for patient care over this period. If the NHS had not been paying profits on PFI schemes, deficits in NHS hospitals would have been reduced by a quarter over this 6 year period.
Over the next 5 years, almost £1bn of taxpayer funds (£973m) will go to PFI companies in the form of pre-tax profits – equivalent to a quarter (22%) of the additional amount of money (£4.5bn) that the government has promised the NHS over this period. A number of PFI schemes are generating particularly high pre-tax profits for their operators. The company which holds the contract for the hospital at University College London has made pre-tax profits of £190m over the past 11 years out. This is out of £527m paid to the company by the NHS. The total value of the hospital is £292m.
Just 8 companies own or have equity stakes in 92% of all the companies holding PFI contracts with the NHS – meaning that there is very little competition between the companies bidding to build and run NHS PFI hospitals.
The report makes a number of recommendations to curtail excess profits, including: Using public sector loans to buy-out PFI contracts. Taxing PFI companies to recoup some of the profits which have been made. Capping the amount of profit which can be made by a private company which has an exclusive public-sector contract with the NHS. Sharing out the profits made from sales of equity stakes in PFI contracts. Mandating greater transparency of equity sales to prevent the unnoticed consolidation of market power by a small number of investors. Re-negotiating contracts with the private companies to reduce the amounts the NHS has to pay.